Global Bleeding Disorders Treatment Market is expected to grow at a CAGR of 7.84% over the Forecast Period of 2019– 2025
Bleeding Disorders Treatment Market is expected to grow at a CAGR of
7.84% between 2019 and 2025 in terms of value. Hemophilia is the most
well-known inherited bleeding disorder in which the blood does not clot
properly. The growing incidences of hemophilia across the world escalate the
demand for bleeding disorders treatment market. As per Hemophilia Federation of
America, four hundred thousand people worldwide were living with hemophilia,
and about 20,000 are living with it in the United States. Furthermore, growing
R&D investment for the development of hemophilia products, rising awareness
about bleeding disorders, and favorable compensation policies are other factors
responsible for the growth of the same. Furthermore, according to the Centers
for Disease Control and Prevention, near about 400 babies were born with
hemophilia each year. However, the high cost of treatment and hemophilia drugs
is likely to hamper the growth of the bleeding disorders treatment market.
Moreover, the development of new drugs that lasts for a longer period of time is
expected to provide fruitful opportunities for market growth.
Geographically, North America holds the largest share in the
bleeding disorder treatment market due to the high prevalence of bleeding
disorder in the U.S. Furthermore, the availability of effective treatments in
the US, and affordability of the U.S. population for lifelong infusion of
expensive drugs contribute to the growth of North America bleeding
disorders treatment market. The Asia Pacific region is anticipated to be the highest growth rate during the forecast period. The growth of this region is
attributed due to growing awareness of bleeding disorders in emerging countries
such as China and India and development in healthcare infrastructures.